The endocrine pancreas

Frediano Inzani; Guido Rindi; Stefano Serra

Chapter 18 - The endocrine pancreas

from Section III - Anatomical endocrine pathology

Published online by Cambridge University Press: 13 April 2017

Frediano Inzani ,

Guido Rindi and

Stefano Serra

Edited by

Ozgur Mete and

Sylvia L. Asa

Show author details

Ozgur Mete: Affiliation:
University of Toronto
Sylvia L. Asa: Affiliation:
University of Toronto

Book contents

Get access

Type: Chapter
Information: Endocrine Pathology , pp. 718 - 742

Publisher: Cambridge University Press

Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Croliss, CE. Patten’s Human Embryology: Elements of Clinical Development. New York: McGraw-Hill, 1976.Google Scholar

Edlund, H. Pancreas: how to get there from the gut? Curr Opin Cell Biol 1999;11:663–668.Google Scholar

Pan, FC, Wright, C. Pancreas organogenesis: from bud to plexus to gland. Dev Dyn 2011;240:530–565.Google Scholar

Yee, NS, Lorent, K, Pack, M. Exocrine pancreas development in zebrafish. Dev Biol 2005;284:84–101.Google Scholar

Herrera, PL. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development 2000;127:2317–2322.Google Scholar

Rovira, M, Scott, SG, Liss, AS, Jensen, J, Thayer, SP, Leach, SD. Isolation and characterization of centroacinar/terminal ductal progenitor cells in adult mouse pancreas. Proc Natl Acad Sci USA 2010;107:75–80.Google Scholar

Carlson, BM. Human Embryology and Developmental Biology, 5th ed. Philadelphia PA: Elsevier-Saunders, 2014.Google Scholar

Klimstra, DS, Hruban, RH, Pitman, MB. Pancreas. In Mills, SE, ed. Histology for Pathologists, 3rd edn. Philadelphia PA: Lippincott Williams & Wilkins, 2007:723–760.Google Scholar

Moore, KL. Clinically Oriented Anatomy. Baltimore, MD: Williams & Wilkins, 1980.Google Scholar

Pansky, B. Anatomy of the pancreas. Emphasis on blood supply and lymphatic drainage. Int J Pancreatol 1990;7:101–108.Google Scholar

Cubilla, AL, Fortner, J, Fitzgerald, PJ. Lymph node involvement in carcinoma of the head of the pancreas area. Cancer 1978;41:880–887.Google Scholar

Heitz, PU, Beglinger, C, Gyr, K. Anatomy and physiology of the exocrine pancreas. In Kloeppel, G, Heitz, PU, eds. Pancreatic Pathology. New York: Churchill-Livingstone, 1984:3–21.Google Scholar

Stamm, BH. Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease. Hum Pathol 1984;15:677–683.Google Scholar

Birnstingl, MA. A study of pancreaticography. Br J Surg 1959;47:128–139.Google Scholar

Williams, JA, Goldfine, ID. The insulin–acinar relationship. In Go, VL, Brooks, FP, DiMagno, EP, Gardner, JD, Lebenthal, E, Scheele, GA, eds. The Exocrine Pancreas: Biology, Pathobiology, and Diseases. New York: Raven Press, 1986:347–360.Google Scholar

Rahier, J, Wallon, J, Henquin, JC. Cell populations in the endocrine pancreas of human neonates and infants. Diabetologia 1981;20:540–546.Google Scholar

Wittingen, J, Frey, CF. Islet concentration in the head, body, tail and uncinate process of the pancreas. Ann Surg 1974;179:412–414.Google Scholar

Stefan, Y, Grasso, S, Perrelet, A, Orci, L. A quantitative immunofluorescent study of the endocrine cell populations in the developing human pancreas. Diabetes 1983;32:293–301.Google Scholar

Grube, D, Bohn, R. The microanatomy of human islets of Langerhans, with special reference to somatostatin (D-) cells. Arch Histol Jpn 1983;46:327–353.Google Scholar

Ehrie, MG, Swartz, FJ. Diploid, tetraploid and octaploid beta cells in the islets of Langerhans of the normal human pancreas. Diabetes 1974;23:583–588.Google Scholar

Malaisse-Lagae, F, Stefan, Y, Cox, J, Perrelet, A, Orci, L. Identification of a lobe in the adult human pancreas rich in pancreatic polypeptide. Diabetologia 1979;17:361–365.Google Scholar

Stefan, Y, Grasso, S, Perrelet, A, Orci, L. The pancreatic polypeptide-rich lobe of the human pancreas: definitive identification of its derivation from the ventral pancreatic primordium. Diabetologia 1982;23:141–142.Google Scholar

Pelletier, G. Identification of four cell types in the human endocrine pancreas by immunoelectron microscopy. Diabetes 1977;26:749–756.Google Scholar

Kloppel, G, Lenzen, S. Anatomy and physiology of the endocrine pancreas. In Kloppel, G, Heitz, PU, eds. Pancreatic Pathology. New York: Churchill-Livingstone, 1984:133–153.Google Scholar

Orci, L, Baetens, D, Ravazzola, M, Stefan, Y, Malaisse-Lagae, F. Pancreatic polypeptide and glucagon: non-random distribution in pancreatic islets. Life Sci 1976;19:1811–1815.Google Scholar

Orci, L, Malaisse-Lagae, F, Baetens, D, Perrelet, A. Pancreatic-polypeptide-rich regions in human pancreas. Lancet 1978;2:1200–1201.Google Scholar

Rindi, G, Buffa, R, Sessa, F, Tortora, O, Solcia, E. Chromogranin A, B and C immunoreactivities of mammalian endocrine cells. Distribution, distinction from costored hormones/prohormones and relationship with the argyrophil component of secretory granules. Histochemistry 1986;85:19–28.Google Scholar

Weidner, N, Tjoe, J. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing’s sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994;18:486–494.Google Scholar

Hochwald, SN, Zee, S, Conlon, KC, Colleoni, R, Louie, O, Brennan, MF, et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002;20:2633–2642.Google Scholar

Fellinger, EJ, Garin-Chesa, P, Triche, TJ, Huvos, AG, Rettig, WJ. Immunohistochemical analysis of Ewing’s sarcoma cell surface antigen p30/32MIC2. Am J Pathol 1991;139:317–325.Google Scholar

Solcia, E, Capella, C, Kloppel, G. Atlas of Tumor Pathology, 3rd Series, Fascicle 20: Tumors of the Pancreas. Washington, DC: Armed Forces Institute of Pathology, 1997.Google Scholar

Chen, J, Baithun, SI, Pollock, DJ, Berry, CL. Argyrophilic and hormone immunoreactive cells in normal and hyperplastic pancreatic ducts and exocrine pancreatic carcinoma. Virchows Arch A Pathol Anat Histopathol 1988;413:399–405.Google Scholar

Adsay, NV, Basturk, O, Saka, B, Bagci, P, Ozdemir, D, Balci, S, et al. Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors. Am J Surg Pathol. 2014;38:480–93.Google Scholar

Hruban, RH, Pitman, MB, Klimstra, DS. Atlas of Tumor Pathology, 4th Series, Fascicle 6: Tumors of the pancreas. Bethesda, MD: ARP Press, 2007.Google Scholar

Klimstra, DS, Modlin, IR, Coppola, D, Lloyd, RV, Suster, S. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 2010;39:707–712.Google Scholar

Klimstra, DS, Modlin, IR, Adsay, NV, Chetty, R, Deshpande, V, Gonen, M, et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol 2010;34:300–313.Google Scholar

Klimstra, DS. Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging. Semin Oncol 2013;40:23–36.Google Scholar

In’t Veld, P. Insulitis in human type 1 diabetes: the quest for an elusive lesion. Islets 2011;3:131–138.Google Scholar

Gianani, R, Campbell-Thompson, M, Sarkar, SA, Wasserfall, C, Pugliese, A, Solis, JM, et al. Dimorphic histopathology of long-standing childhood-onset diabetes. Diabetologia 2010;53:690–698.Google Scholar

Itoh, N, Hanafusa, T, Miyazaki, A, Miyagawa, J, Yamagata, K, Yamamoto, K, et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 1993;92:2313–2322.Google Scholar

Butler, AE, Galasso, R, Meier, JJ, Basu, R, Rizza, RA, Butler, PC. Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis. Diabetologia 2007;50:2323–2331.Google Scholar

Clark, A, de Koning, EJ, Hattersley, AT, Hansen, BC, Yajnik, CS, Poulton, J. Pancreatic pathology in non-insulin dependent diabetes (NIDDM). Diabetes Res Clin Pract 1995;28(suppl):S39–S47.Google Scholar

Rindi, G, Solcia, E. Endocrine hyperplasia and dysplasia in the pathogenesis of gastrointestinal and pancreatic endocrine tumors. Gastroenterol Clin North Am 2007;36:851–865, vi.Google Scholar

Weidenheim, KM, Hinchey, WW, Campbell, WG Jr. Hyperinsulinemic hypoglycemia in adults with islet-cell hyperplasia and degranulation of exocrine cells of the pancreas. Am J Clin Pathol 1983;79:14–24.Google Scholar

Ueda, Y, Kurihara, K, Kondoh, T, Okanoue, T, Chiba, T. Islet-cell hyperplasia causing hyperinsulinemic hypoglycemia in an adult. J Gastroenterol 1998;33:125–128.Google Scholar

Kim, YW, Park, YK, Park, JH, Lee, SM, Lee, J, Ko, SW, et al. Islet cell hyperplasia of the pancreas presenting as hyperinsulinemic hypoglycemia in an adult. Yonsei Med J 2000;41:426–429.Google Scholar

Starke, A, Saddig, C, Kirch, B, Tschahargane, C, Goretzki, P. Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome. World J Surg 2006;30:670–679.Google Scholar

Asa, SL. Pancreatic endocrine tumors. Modern Pathol 2011;24(Suppl 2):S66–S77.Google Scholar

Chetty, R, Kennedy, M, Ezzat, S, Asa, SL. Pancreatic endocrine pathology in von Hippel–Lindau disease: an expanding spectrum of lesions. Endocr Pathol 2004; 15:141–148.Google Scholar

Anlauf, M, Schlenger, R, Perren, A, Bauersfeld, J, Koch, CA, Dralle, H, et al. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. Am J Surg Pathol 2006;30:560–574.Google Scholar

Perigny, M, Hammel, P, Corcos, O, Larochelle, O, Giraud, S, Richard, S, et al. Pancreatic endocrine microadenomatosis in patients with von Hippel–Lindau disease: characterization by VHL/HIF pathway proteins expression. Am J Surg Pathol 2009;33:739–748.Google Scholar

Laidlaw, GF. Nesidioblastoma, the islet tumor of the pancreas. Am J Pathol 1938;14:125–134.Google Scholar

Ouyang, D, Dhall, D, Yu, R. Pathologic pancreatic endocrine cell hyperplasia. World J Gastroenterol 2011;17:137–143.Google Scholar

Shah, JH, Maguire, DJ, Brown, D, Cotterill, A. The role of ATP sensitive channels in insulin secretion and the implications in persistent hyperinsulinemic hypoglycaemia of infancy (PHHI). Adv Exp Med Biol 2007;599:133–138.Google Scholar

Kapoor, RR, James, C, Hussain, K. Hyperinsulinism in developmental syndromes. Endocr Dev 2009;14:95–113.Google Scholar

Paloyan, E, Lawrence, AM, Straus, FH 2nd, Paloyan, D, Harper, PV, Cummings, D. Alpha cell hyperplasia in calcific pancreatitis associated with hyperparathyroidism. JAMA 1967;200:757–761.Google Scholar

Henopp, T, Anlauf, M, Schmitt, A, Schlenger, R, Zalatnai, A, Couvelard, A, et al. Glucagon cell adenomatosis: a newly recognized disease of the endocrine pancreas. J Clin Endocrinol Metab 2009;94:213–217.Google Scholar

Zhou, C, Dhall, D, Nissen, NN, Chen, CR, Yu, R. Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor. Pancreas 2009;38:941–946.Google Scholar

Yu, R, Nissen, NN, Dhall, D, Heaney, AP. Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: review of the literature. Pancreas 2008;36:428–431.Google Scholar

Mansour, JC, Chen, H. Pancreatic endocrine tumors. J Surg Res 2004;120:139–161.Google Scholar

Rindi, G, Falconi, M, Klersy, C, Albarello, L, Boninsegna, L, Buchler, MW, et al. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 2012;104:764–777.Google Scholar

Ellison, TA, Wolfgang, CL, Shi, C, Cameron, JL, Murakami, P, Mun, LJ, et al. A single institution’s 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram. Ann Surg 2014;259:204–212.Google Scholar

Klimstra, DS, Arnold, R, Capella, C, Klöppel, G, Komminoth, P, Solcia, E, et al. Neuroendocrine neoplasms of the pancreas. In Bosman, F, Carneiro, F, eds. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer, 2010:322–330.Google Scholar

Rindi, G, Arnold, R, Capella, C, Klimstra, DS, Klöppel, G, Komminoth, P, et al. Nomenclature and classification of digestive neuroendocrine tumours. In Bosman, F, Carneiro, F, eds. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer, 2010:10–12.Google Scholar

Bosman, F, Carneiro, F. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer, 2010.Google Scholar

Rindi, G, Leiter, AB, Kopin, AS, Bordi, C, Solcia, E. The “normal” endocrine cell of the gut: changing concepts and new evidences. Ann N Y Acad Sci 2004;1014:1–12.Google Scholar

Rindi, G, Wiedenmann, B. Neuroendocrine neoplasms of the gut and pancreas: new insights. Nature reviews. Endocrinology 2012;8:54–64.Google Scholar

Falconi, M, Bartsch, DK, Eriksson, B, Kloppel, G, Lopes, JM, O’Connor, JM, et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors. Neuroendocrinology 2012;95:120–134.Google Scholar

Rindi, G, Kloppel, G, Alhman, H, Caplin, M, Couvelard, A, de Herder, WW, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006;449:395–401.Google Scholar

Goodell, PP, Krasinskas, AM, Davison, JM, Hartman, DJ. Comparison of methods for proliferative index analysis for grading pancreatic well-differentiated neuroendocrine tumors. Am J Clin Pathol 2012;137:576–582.Google Scholar

McCall, CM, Shi, C, Cornish, TC, Klimstra, DS, Tang, LH, Basturk, O, et al. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. Am J Surg Pathol 2013;37:1671–1677.Google Scholar

Couvelard, A, Deschamps, L, Ravaud, P, Baron, G, Sauvanet, A, Hentic, O, et al. Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors. Mod Pathol 2009;22:273–281.Google Scholar

Yang, Z, Tang, LH, Klimstra, DS. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Am J Surg Pathol 2011;35:853–860.Google Scholar

Sobin, L, Gospodarowicz, M, Wittekind, C. TNM Classification of Malignant Tumours, 7th edn. Bognor Regis, UK: Wiley Blackwell, 2009.Google Scholar

Edge, SB, Byrd, DR, Compton, CC, Fritz, AG, Greene, FL, Trotti, A. AJCC Cancer Staging Manual. New York: Springer, 2010.Google Scholar

Franko, J, Feng, W, Yip, L, Genovese, E, Moser, AJ. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2158 patients. J Gastrointest Surg 2010;14:541–548.Google Scholar

Basturk, O, Tang, L, Hruban, RH, Adsay, V, Yang, Z, Krasinskas, AM, et al. Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases. Am J Surg Pathol 2014;38:437–447.Google Scholar

Morohoshi, T, Held, G, Kloppel, G. Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases. Histopathology 1983;7:645–661.Google Scholar

O’Connor, TP, Wade, TP, Sunwoo, YC, Reimers, HJ, Palmer, DC, Silverberg, AB, et al. Small cell undifferentiated carcinoma of the pancreas. Report of a patient with tumor marker studies. Cancer 1992;70:1514–1519.Google Scholar

Fischer, L, Kleeff, J, Esposito, I, Hinz, U, Zimmermann, A, Friess, H, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008;95:627–635.Google Scholar

Pape, UF, Jann, H, Muller-Nordhorn, J, Bockelbrink, A, Berndt, U, Willich, SN, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 2008;113:256–265.Google Scholar

Scarpa, A, Mantovani, W, Capelli, P, Beghelli, S, Boninsegna, L, Bettini, R, et al. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 2010;23:824–833.Google Scholar

de Herder, WW, Niederle, B, Scoazec, JY, Pauwels, S, Kloppel, G, Falconi, M, et al. Well-differentiated pancreatic tumor/carcinoma: insulinoma. Neuroendocrinology 2006;84:183–188.Google Scholar

Mathur, A, Gorden, P, Libutti, SK. Insulinoma. Surg Clin North Am 2009;89:1105–1121.Google Scholar

Oberg, K. Pancreatic endocrine tumors. Semin Oncol 2010;37:594–618.Google Scholar

Vanderveen, K, Grant, C. Insulinoma. Cancer Treat Res 2010;153:235–252.Google Scholar

Jensen, RT. Pancreatic endocrine tumors: recent advances. Ann Oncol 1999;10(suppl 4):170–176.Google Scholar

Kent, RB 3rd, van Heerden, JA, Weiland, LH. Nonfunctioning islet cell tumors. Ann Surg 1981;193:185–190.Google Scholar

Debas, HT, Mulvihill, SJ. Neuroendocrine gut neoplasms. Important lessons from uncommon tumors. Arch Surg 1994;129:965–71; discussion 71–72.Google Scholar

Caudill, JL, Humphrey, SK, Salomao, DR. Islet cell tumor of the pancreas: increasing diagnosis after instituting ultrasonography-guided fine needle aspiration. Acta Cytol 2008;52:45–51.Google Scholar

Chatzipantelis, P, Salla, C, Konstantinou, P, Karoumpalis, I, Sakellariou, S, Doumani, I. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases. Cancer 2008;114:255–262.Google Scholar

Larghi, A, Capurso, G, Carnuccio, A, Ricci, R, Alfieri, S, Galasso, D, et al. Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Gastrointest Endosc 2012;76:570–577.Google Scholar

Larghi, A, Lugli, F, Sharma, V, Carnuccio, A, Anastasi, F, Fusco, A, et al. Pancreatic metastases from a bronchopulmonary carcinoid diagnosed by endoscopic ultrasonography-guided fine-needle tissue acquisition. Pancreas 2012;41:502–504.Google Scholar

McLean, AM, Fairclough, PD. Endoscopic ultrasound in the localisation of pancreatic islet cell tumours. Best practice and research. Clin Endocrinol Metab 2005;19:177–193.Google Scholar

Rosch, T, Lightdale, CJ, Botet, JF, Boyce, GA, Sivak, MV Jr., Yasuda, K, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992;326:1721–1726.Google Scholar

Sundin, A, Vullierme, MP, Kaltsas, G, Plöckinger, U, Mallorca Consensus Conference Participants, European Neuroendocrine Tumor Society. ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological examinations. Neuroendocrinology 2009;90:167–183.Google Scholar

Quaia, E, Stacul, F, Gaiani, S, Ricci, P, Passariello, R, Curzio, D, et al. Comparison of diagnostic performance of unenhanced vs SonoVue: enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers. Radiol Med 2004;108:71–81.Google Scholar

D’Onofrio, M, Mansueto, G, Falconi, M, Procacci, C. Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. Abdom Imaging 2004;29:246–258.Google Scholar

Ichikawa, T, Peterson, MS, Federle, MP, Baron, RL, Haradome, H, Kawamori, Y, et al. Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. Radiology 2000;216:163–171.Google Scholar

Owen, NJ, Sohaib, SA, Peppercorn, PD, Monson, JP, Grossman, AB, Besser, GM, et al. MRI of pancreatic neuroendocrine tumours. Br J Radiol 2001;74:968–973.Google Scholar

Ricke, J, Klose, KJ. Imaging procedures in neuroendocrine tumours. Digestion 2000;62(suppl 1):39–44.Google Scholar

Koukouraki, S, Strauss, LG, Georgoulias, V, Eisenhut, M, Haberkorn, U, Dimitrakopoulou-Strauss, A. Comparison of the pharmacokinetics of ⁶⁸Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for ⁹⁰Y-DOTATOC therapy. Eur J Nucl Med Mol Imaging 2006;33:1115–1122.Google Scholar

al-Kaisi, N, Weaver, MG, Abdul-Karim, FW, Siegler, E. Fine needle aspiration cytology of neuroendocrine tumors of the pancreas. A cytologic, immunocytochemical and electron microscopic study. Acta Cytol 1992;36:655–660.Google Scholar

Bell, DA. Cytologic features of islet-cell tumors. Acta Cytol 1987;31:485–492.Google Scholar

Collins, BT, Cramer, HM. Fine-needle aspiration cytology of islet cell tumors. Diagn Cytopathol 1996;15:37–45.Google Scholar

Koss, LG, Melamed, MR. Koss’ Diagnostic Cytology and its Histopathologic Bases. Philadelphia, PA: Lippincott Williams & Wilkins, 2006.Google Scholar

Carstens, PH, Cressman, FK Jr. Malignant oncocytic carcinoid of the pancreas. Ultrastruct Pathol 1989;13:69–75.Google Scholar

Gotchall, J, Traweek, ST, Stenzel, P. Benign oncocytic endocrine tumor of the pancreas in a patient with polyarteritis nodosa. Hum Pathol 1987;18:967–969.Google Scholar

Hoang, MP, Hruban, RH, Albores-Saavedra, J. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel–Lindau disease. Am J Surg Pathol 2001;25:602–609.Google Scholar

Perez-Montiel, MD, Frankel, WL, Suster, S. Neuroendocrine carcinomas of the pancreas with “rhabdoid” features. Am J Surg Pathol 2003;27:642–649.Google Scholar

Scoazec, JY, Couvelard, A, Monges, G, Leteurtre, E, Belleanee, G, Guyetant, S, et al. Well-differentiated grade 3 digestive neuroendocrine tumors: myth or reality? The PRONET study group. J Clin Oncol 2012;30:(suppl):abstract 4129.Google Scholar

Hijioka, S, Hosoda, W, Mizuno, N, Hara, K, Imaoka, H, Bhatia, V, et al. Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas? J Gastroenterol 2014;50:564–572.Google Scholar

Rindi, G, Petrone, G, Inzani, F. The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction. Endocr Pathol 2014;25:186–192.Google Scholar

Lloyd, RV, Mervak, T, Schmidt, K, Warner, TF, Wilson, BS. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms. Am J Surg Pathol 1984;8:607–614.Google Scholar

Mukai, K, Grotting, JC, Greider, MH, Rosai, J. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Am J Surg Pathol 1982;6:387–399.Google Scholar

Rindi, G, Bordi, C, La Rosa, S, Solcia, E, Delle Fave, G, Gruppo Italiano Patologi Apparato Digerente, et al. Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report. Digest Liver Dis 2011;43(suppl 4):S356–S360.Google Scholar

Larsson, LI, Grimelius, L, Hakanson, R, Rehfeld, JF, Stadil, F, Holst, J, et al. Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol 1975;79:271–284.Google Scholar

Volante, M, Brizzi, MP, Faggiano, A, La Rosa, S, Rapa, I, Ferrero, A, et al. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 2007;20:1172–1182.Google Scholar

Agaimy, A, Erlenbach-Wunsch, K, Konukiewitz, B, Schmitt, AM, Rieker, RJ, Vieth, M, et al. ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin. Mod Pathol 2013;26:995–1003.Google Scholar

Hermann, G, Konukiewitz, B, Schmitt, A, Perren, A, Kloppel, G. Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2. Virchows Arch 2011;459:147–154.Google Scholar

Koo, J, Mertens, RB, Mirocha, JM, Wang, HL, Dhall, D. Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin. Mod Pathol 2012;25:893–901.Google Scholar

Schmitt, AM, Riniker, F, Anlauf, M, Schmid, S, Soltermann, A, Moch, H, et al. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. Am J Surg Pathol 2008;32:420–425.Google Scholar

Chandrasekharappa, SC, Guru, SC, Manickam, P, Olufemi, SE, Collins, FS, Emmert-Buck, MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404–407.Google Scholar

Verhoef, S, van Diemen-Steenvoorde, R, Akkersdijk, WL, Bax, NM, Ariyurek, Y, Hermans, CJ, et al. Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood. Eur J Pediatr 1999;158:284–287.Google Scholar

Latif, F, Tory, K, Gnarra, J, Yao, M, Duh, FM, Orcutt, ML, et al. Identification of the von Hippel–Lindau disease tumor suppressor gene. Science 1993;260:1317–1320.Google Scholar

Francalanci, P, Diomedi-Camassei, F, Purificato, C, Santorelli, FM, Giannotti, A, Dominici, C, et al. Malignant pancreatic endocrine tumor in a child with tuberous sclerosis. Am J Surg Pathol 2003;27:1386–1389.Google Scholar

Cupisti, K, Hoppner, W, Dotzenrath, C, Simon, D, Berndt, I, Roher, HD, et al. Lack of MEN1 gene mutations in 27 sporadic insulinomas. Eur J Clin Invest 2000;30:325–329.Google Scholar

D’Adda, T, Pizzi, S, Azzoni, C, Bottarelli, L, Crafa, P, Pasquali, C, et al. Different patterns of 11q allelic losses in digestive endocrine tumors. Hum Pathol 2002;33:322–329.Google Scholar

Gortz, B, Roth, J, Krahenmann, A, de Krijger, RR, Muletta-Feurer, S, Rutimann, K, et al. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms. Am J Pathol 1999;154:429–436.Google Scholar

Hessman, O, Lindberg, D, Einarsson, A, Lillhager, P, Carling, T, Grimelius, L, et al. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors. Genes Chromosomes Cancer 1999;26:258–264.Google Scholar

Moore, PS, Missiaglia, E, Antonello, D, Zamo, A, Zamboni, G, Corleto, V, et al. Role of disease-causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. Genes Chromosomes Cancer 2001;32:177–181.Google Scholar

Jiao, Y, Shi, C, Edil, BH, de Wilde, RF, Klimstra, DS, Maitra, A, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011;331:1199–1203.Google Scholar

Corbo, V, Dalai, I, Scardoni, M, Barbi, S, Beghelli, S, Bersani, S, et al. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases. Endocr Relat Cancer 2010;17:771–783.Google Scholar

Chung, DC, Smith, AP, Louis, DN, Graeme-Cook, F, Warshaw, AL, Arnold, A. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. J Clin Invest 1997;100:404–410.Google Scholar

Hruban, RH, Iacobuzio-Donahue, C, Wilentz, RE, Goggins, M, Kern, SE. Molecular pathology of pancreatic cancer. Cancer J 2001;7:251–258.Google Scholar

Perren, A, Komminoth, P, Saremaslani, P, Matter, C, Feurer, S, Lees, JA, et al. Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol 2000;157:1097–1103.Google Scholar

Roldo, C, Missiaglia, E, Hagan, JP, Falconi, M, Capelli, P, Bersani, S, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006;24:4677–4684.Google Scholar

Serrano, J, Goebel, SU, Peghini, PL, Lubensky, IA, Gibril, F, Jensen, RT. Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas. J Clin Endocrinol Metab 2000;85:4146–4156.Google Scholar

Yachida, S, Vakiani, E, White, CM, Zhong, Y, Saunders, T, Morgan, R, et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 2012;36:173–184.Google Scholar

Furlan, D, Cerutti, R, Uccella, S, La Rosa, S, Rigoli, E, Genasetti, A, et al. Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract. Clin Cancer Res 2004;10:947–957.Google Scholar

Jonkers, YM, Claessen, SM, Perren, A, Schmitt, AM, Hofland, LJ, de Herder, W, et al. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocr Relat Cancer 2007;14:769–779.Google Scholar

Pizzi, S, Azzoni, C, Bassi, D, Bottarelli, L, Milione, M, Bordi, C. Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer 2003;98:1273–1282.Google Scholar

Rigaud, G, Missiaglia, E, Moore, PS, Zamboni, G, Falconi, M, Talamini, G, et al. High resolution allelotype of nonfunctional pancreatic endocrine tumors: identification of two molecular subgroups with clinical implications. Cancer Res 2001;61:285–292.Google Scholar

Missiaglia, E, Dalai, I, Barbi, S, Beghelli, S, Falconi, M, della Peruta, M, et al. Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol 2010;28:245–255.Google Scholar

de Wilde, RF, Heaphy, CM, Maitra, A, Meeker, AK, Edil, BH, Wolfgang, CL, et al. Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod Pathol 2012;25:1033–1039.Google Scholar

Corbo, V, Beghelli, S, Bersani, S, Antonello, D, Talamini, G, Brunelli, M, et al. Pancreatic endocrine tumours: mutational and immunohistochemical survey of protein kinases reveals alterations in targetable kinases in cancer cell lines and rare primaries. Ann Oncol 2012;23:127–134.Google Scholar

Marinoni, I, Kurrer, AS, Vassella, E, Dettmer, M, Rudolph, T, Banz, V, et al. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Gastroenterology 2014;146:453–460 e5.Google Scholar

Malpeli, G, Amato, E, Dandrea, M, Fumagalli, C, Debattisti, V, Boninsegna, L, et al. Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors. BMC Cancer 2011;11:351.Google Scholar

Stefanoli, M, La Rosa, S, Sahnane, N, Romualdi, C, Pastorino, R, Marando, A, et al. Prognostic relevance of aberrant DNA methylation in G1 and G2 pancreatic neuroendocrine tumors. Neuroendocrinology 2014;100:26–34.Google Scholar

Jensen, RT, Cadiot, G, Brandi, ML, de Herder, WW, Kaltsas, G, Komminoth, P, et al. ENETS consensus guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology 2012;95:98–119.Google Scholar

Kulke, MH, Anthony, LB, Bushnell, DL, de Herder, WW, Goldsmith, SJ, Klimstra, DS, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 2010;39:735–752.Google Scholar

Oberg, K, Knigge, U, Kwekkeboom, D, Perren, A. Neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012;23(suppl 7):vii124–130.Google Scholar

Yao, JC, Shah, MH, Tetsuhide, I, Lombard Bohas, C, Wolin, EM, Van Cutsem, E, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011;364:514–523.Google Scholar

Raymond, E, Dahan, L, Raoul, JL, Bang, YJ, Borbath, I, Lombard-Bohas, C, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011;364:501–513.Google Scholar

Caplin, ME, Pavel, M, Cwikla, JB, Phan, AT, Raderer, M, Sedlackova, E, et al. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med 2014;371:224–233.Google Scholar

Caplin, ME, Pavel, M, Ruszniewski, P. Lanreotide in metastatic enteropancreatic neuroendocrine tumors. N Engl J Med 2014;371:1556–1557.Google Scholar

Rinke, A, Muller, HH, Schade-Brittinger, C, Klose, KJ, Barth, P, Wied, M, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 2009;27:4656–4663.Google Scholar

Ekeblad, S, Skogseid, B, Dunder, K, Oberg, K, Eriksson, B. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 2008;14:7798–7803.Google Scholar

Ferrone, CR, Tang, LH, Tomlinson, J, Gonen, M, Hochwald, SN, Brennan, MF, et al. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol 2007;25:5609–5615.Google Scholar

La Rosa, S, Klersy, C, Uccella, S, Dainese, L, Albarello, L, Sonzogni, A, et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 2009;40:30–40.Google Scholar

Schmitt, AM, Anlauf, M, Rousson, V, Schmid, S, Kofler, A, Riniker, F, et al. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am J Surg Pathol 2007;31:1677–1682.Google Scholar

Reyes, CV, Wang, T. Undifferentiated small cell carcinoma of the pancreas: a report of five cases. Cancer 1981;47:2500–2502.Google Scholar

Morant, R, Bruckner, HW. Complete remission of refractory small cell carcinoma of the pancreas with cisplatin and etoposide. Cancer 1989;64:2007–2009.Google Scholar

Rindi, G, Klersy, C, Inzani, F, Fellegara, G, Ampollini, L, Ardizzoni, A, et al. Grading the neuroendocrine tumors of the lung: an evidence-based proposal. Endocr Relat Cancer 2014;21:1–16.Google Scholar

Travis, WD, Rush, W, Flieder, DB, Falk, R, Fleming, MV, Gal, AA, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998;22:934–944.Google Scholar

Righi, L, Volante, M, Tavaglione, V, Bille, A, Daniele, L, Angusti, T, et al. Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 “clinically aggressive” cases. Ann Oncol 2010;21:548–555.Google Scholar

den Bakker, MA, Willemsen, S, Grunberg, K, Noorduijn, LA, van Oosterhout, MF, van Suylen, RJ, et al. Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability. Histopathology 2010;56:356–363.Google Scholar

Ha, SY, Han, J, Kim, WS, Suh, BS, Roh, MS. Interobserver variability in diagnosing high-grade neuroendocrine carcinoma of the lung and comparing it with the morphometric analysis. Korean J Pathol 2012;46:42–47.Google Scholar

Sorbye, H, Welin, S, Langer, SW, Vestermark, LW, Holt, N, Osterlund, P, et al. Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. Ann Oncol 2013;24:152–160.Google Scholar

Velayoudom-Cephise, FL, Duvillard, P, Foucan, L, Hadoux, J, Chougnet, CN, Leboulleux, S, et al. Are G3 ENETS neuroendocrine neoplasms heterogeneous? Endocr Relat Cancer 2013;20:649–657.Google Scholar

Falconi, M, Plöckinger, U, Kwekkeboom, DJ, Manfredi, R, Korner, M, Kvols, L, et al. Well-differentiated pancreatic nonfunctioning tumors/carcinoma. Neuroendocrinology 2006;84:196–211.Google Scholar

Guettier, JM, Gorden, P. Insulin secretion and insulin-producing tumors. Exp Rev Endocrinol Metab 2010;5:217–227.Google Scholar

Metz, DC, Jensen, RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 2008;135:1469–1492.Google Scholar

Pelosi, G, Bresaola, E, Bogina, G, Pasini, F, Rodella, S, Castelli, P, et al. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy. A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol 1996;27:1124–1134.Google Scholar

La Rosa, S, Rigoli, E, Uccella, S, Novario, R, Capella, C. Prognostic and biological significance of cytokeratin 19 in pancreatic endocrine tumours. Histopathology 2007;50:597–606.Google Scholar

Chaudhry, A, Gobl, A, Eriksson, B, Skogseid, B, Oberg, K. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors. Cancer Res 1994;54:981–986.Google Scholar

Rahman, A, Maitra, A, Ashfaq, R, Yeo, CJ, Cameron, JL, Hansel, DE. Loss of p27 nuclear expression in a prognostically favorable subset of well-differentiated pancreatic endocrine neoplasms. Am J Clin Pathol 2003;120:685–690.Google Scholar

Book contents

Chapter 18 - The endocrine pancreas

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive